Medicine composition prepared from alanyl glutamine and compound amino acid by utilizing spray drying method

A technology of alanyl glutamine and compound amino acids, applied in the field of medicine, can solve the problems of unfavorable wide application of alanyl glutamine and amino acids, great difference in drug quality, influence on drug quality, etc., and achieves improvement of clinical application quality. and bioavailability, ease of procurement and dispensing, and efficacy in reducing liver damage

Inactive Publication Date: 2013-09-25
灵康药业集团股份有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, in China, the compatible application of alanyl glutamine for injection and compound amino acid injection is purchased by the drug unit from different manufacturers, and they are combined together during clinical application. In this way, the quality of the drug may vary due to different manufacturers. The difference is very large, and the compatibility application seriously affects the quality of the final drug, which further affects the treatment of patients
[0007] Patent document CN201223558Y discloses a double-chamber infusion bag containing amino acid injection and alanyl glutamine injection, but alanyl glutamine exists in the form of solution, which is unstable when left for a long time and will degrade
Zhou Xin and others pointed out that alanyl glutamine plus compound amino acid injection caused liver damage, which is not conducive to the wide application of alanyl glutamine and amino acid combination
[0008] In order to overcome the difficult technical problems existing in the combination of alanyl glutamine and compound amino acids in the prior art, the inventor proposes a new pharmaceutical composition of alanyl glutamine and compound amino acids and its application packaging

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition prepared from alanyl glutamine and compound amino acid by utilizing spray drying method
  • Medicine composition prepared from alanyl glutamine and compound amino acid by utilizing spray drying method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Example 1 Preparation of Combination Packaged Drugs

[0040] Composition: Alanyl glutamine sterile powder for injection 10g, water for injection 50ml and compound amino acid injection 250ml

[0041] making process:

[0042] 1. Preparation of Alanyl Glutamine for Injection

[0043] (1) Dissolve 1000g of alanylglutamine and 5000ml of water for injection in the batching room of the 10,000-class clean area to make a solution of about 20%, add 15g of medicinal activated carbon, stir and absorb for 30 minutes, and decarbonize by coarse filtration. After fine filtration through a 0.22 μm microporous membrane, the filtrate was spray-dried to obtain alanyl glutamine sterile powder.

[0044] (2) Class 100 clean area, under the condition of class 100, the relative humidity is controlled to be lower than 45%, and the automatic packaging machine is used for aseptic packaging, 10g / bottle, stoppered, and capped.

[0045] 2. Preparation of water for injection

[0046] Fill with fr...

Embodiment 2

[0053] Example 2 Preparation of Combination Packaged Drugs

[0054] Combination: 20g of alanyl glutamine powder for injection, 100ml of water for injection and 500ml of compound amino acid injection

[0055] making process:

[0056] 1. Preparation of Alanyl Glutamine for Injection

[0057] (1) Dissolve 2000g of alanylglutamine and 10000ml of water for injection in the batching room of the 10,000-class clean area to make a solution of about 20%, add 30g of medicinal activated carbon, stir and absorb for 30 minutes, and decarbonize by coarse filtration. After fine filtration through a 0.22 μm microporous membrane, the filtrate was spray-dried to obtain alanyl glutamine sterile powder.

[0058] (2) Class 100 clean area, under the condition of class 100, the relative humidity is controlled to be lower than 45%, and the automatic filling machine is used for aseptic subpackaging, 20g / bottle, stoppered and capped.

[0059] 2. Preparation of water for injection

[0060] Fill wit...

experiment example 3

[0067] Experimental example 3 Stability test

[0068] A batch of samples were prepared according to Example 1 of 201110267409.6, and compared with the samples prepared in Example 1 of the present invention, an accelerated test was carried out at a high temperature of 40°C and a relative humidity of 75%±5% for 6 months. The results are shown in Table 1.

[0069] Table 1 Stability and dissolution rate determination results

[0070]

[0071] As can be seen from Table 1, the dissolution rate of the sample prepared in Example 1 of 201110267409.6 is significantly slow, and the relevant substances increase during the acceleration of 6 months; while the dissolution rate of the sample prepared in Example 1 of the present invention is very fast, and the relevant substances change after 6 months of acceleration smaller. It fully demonstrates the superiority of the present invention in improving stability and dissolution rate.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicine composition prepared from alanyl glutamine sterile powder for injection and a compound amino acid injection by utilizing a spray drying method, especially a composition application package. The composition application package comprises the alanyl glutamine sterile powder for injection, water for injection and the compound amino acid injection. By the composition application package, the requirement of clinical medication is greatly met, the purchasing and the dispensation of medication units are also greatly facilitated, and the cost is saved. The composition application package is prepared just before use, is of great benefit to the stability of every independent medicine, and can be used for increasing the clinical application quality and the bioavailability of medicines. The medicine composition has the benefit that the liver injury is obviously reduced.

Description

technical field [0001] The invention relates to a pharmaceutical composition of alanyl glutamine and compound amino acid, in particular to a combined application package of alanyl glutamine sterile powder for injection and compound amino acid injection prepared by spray drying method, belonging to field of medical technology. Background technique [0002] L-Glutamine (Gln) is an essential amino acid in the body and the most abundant amino acid in the human body. It plays an important role in the synthesis of proteins and nucleic acids. The content of Gln in plasma is as high as 0.8-0.9 mmol / L, accounting for about 20% of the total free amino acids. Gln is the energy source of metabolically active cells such as intestinal mucosal epithelial cells, renal tubular epithelial cells, and immunocompetent cells; it is considered to be the body's nitrogen source carrier, transporting nitrogen sources between tissues in the body, and playing an important role in removing ammonia and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/05A61K9/14A61P3/02A61K31/198A61K31/401A61K31/405A61K31/4172
Inventor 陶灵刚
Owner 灵康药业集团股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products